Maas R - Search Results

1

Pharmacology and clinical pharmacology of methylarginines used as inhibitors of nitric oxide synthases.

Kittel A, Maas R. Kittel A, et al. Among authors: maas r. Curr Pharm Des. 2014;20(22):3530-47. doi: 10.2174/13816128113196660750. Curr Pharm Des. 2014. PMID: 24180385 Review.

2

Pharmacotherapies and their influence on asymmetric dimethylargine (ADMA).

Maas R. Maas R. Vasc Med. 2005 Jul;10 Suppl 1:S49-57. doi: 10.1191/1358863x05vm605oa. Vasc Med. 2005. PMID: 16444869 Review.

3

Asymmetric dimethylarginine, smoking, and risk of coronary heart disease in apparently healthy men: prospective analysis from the population-based Monitoring of Trends and Determinants in Cardiovascular Disease/Kooperative Gesundheitsforschung in der Region Augsburg study and experimental data.

Maas R, Schulze F, Baumert J, Löwel H, Hamraz K, Schwedhelm E, Koenig W, Böger RH. Maas R, et al. Clin Chem. 2007 Apr;53(4):693-701. doi: 10.1373/clinchem.2006.081893. Epub 2007 Feb 22. Clin Chem. 2007. PMID: 17317881

4

Elevated plasma concentrations of the endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine predict adverse events in patients undergoing noncardiac surgery.

Maas R, Dentz L, Schwedhelm E, Thoms W, Kuss O, Hiltmeyer N, Haddad M, Klöss T, Standl T, Böger RH. Maas R, et al. Crit Care Med. 2007 Aug;35(8):1876-81. doi: 10.1097/01.CCM.0000277038.11630.71. Crit Care Med. 2007. PMID: 17581491

5

Pharmacokinetic and pharmacodynamic properties of oral L-citrulline and L-arginine: impact on nitric oxide metabolism.

Schwedhelm E, Maas R, Freese R, Jung D, Lukacs Z, Jambrecina A, Spickler W, Schulze F, Böger RH. Schwedhelm E, et al. Among authors: maas r. Br J Clin Pharmacol. 2008 Jan;65(1):51-9. doi: 10.1111/j.1365-2125.2007.02990.x. Epub 2007 Jul 27. Br J Clin Pharmacol. 2008. PMID: 17662090 Free PMC article. Clinical Trial.

6

ADMA and the role of the genes: lessons from genetically modified animals and human gene polymorphisms.

Maas R, Böger R, Lüneburg N. Maas R, et al. Pharmacol Res. 2009 Dec;60(6):475-80. doi: 10.1016/j.phrs.2009.07.012. Epub 2009 Aug 8. Pharmacol Res. 2009. PMID: 19666122 Review.

7

Symmetric dimethylarginine predicts all-cause mortality following ischemic stroke.

Schulze F, Carter AM, Schwedhelm E, Ajjan R, Maas R, von Holten RA, Atzler D, Grant PJ, Böger RH. Schulze F, et al. Among authors: maas r. Atherosclerosis. 2010 Feb;208(2):518-23. doi: 10.1016/j.atherosclerosis.2009.06.039. Epub 2009 Jul 23. Atherosclerosis. 2010. PMID: 19700158

8

The role of nitric oxide synthase inhibition by asymmetric dimethylarginine in the pathophysiology of preeclampsia.

Böger RH, Diemert A, Schwedhelm E, Lüneburg N, Maas R, Hecher K. Böger RH, et al. Among authors: maas r. Gynecol Obstet Invest. 2010;69(1):1-13. doi: 10.1159/000245940. Epub 2009 Oct 14. Gynecol Obstet Invest. 2010. PMID: 19828999 Review.

9

In vivo evidence that Agxt2 can regulate plasma levels of dimethylarginines in mice.

Kittel A, Maas R, König J, Mieth M, Weiss N, Jarzebska N, Hohenstein B, Martens-Lobenhoffer J, Bode-Böger SM, Rodionov RN. Kittel A, et al. Among authors: maas r. Biochem Biophys Res Commun. 2013 Jan 4;430(1):84-9. doi: 10.1016/j.bbrc.2012.11.008. Epub 2012 Nov 12. Biochem Biophys Res Commun. 2013. PMID: 23154179

10

Alanine-glyoxylate aminotransferase 2 (AGXT2) polymorphisms have considerable impact on methylarginine and β-aminoisobutyrate metabolism in healthy volunteers.

Kittel A, Müller F, König J, Mieth M, Sticht H, Zolk O, Kralj A, Heinrich MR, Fromm MF, Maas R. Kittel A, et al. Among authors: maas r. PLoS One. 2014 Feb 24;9(2):e88544. doi: 10.1371/journal.pone.0088544. eCollection 2014. PLoS One. 2014. PMID: 24586340 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

757 results

Search Page